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ABSTRACT 
Joleyn Yean Chern Khoo 
THE ROLE OF THE BORRELIA OXIDATIVE STRESS REGULATOR PROTEIN IN 
VIRULENCE GENE EXPRESSION OF THE LYME DISEASE SPIROCHETE 
The Lyme disease agent, Borrelia burgdorferi, has a complex system that allows 
it to thrive in the harsh and distinct environments of its tick vector and mammalian host. 
Although it has been known for some time that the Borrelia oxidative stress regulator 
protein (BosR) plays a necessary role in mammalian infectivity and functions as 
a transcriptional regulator of alternative sigma factor RpoS, very little is known about its 
mechanism of action, other than the suggestion that BosR activates rpoS transcription by 
binding to certain upstream regions of the gene. In our studies, we performed protein 
degradation assays and luciferase reporter assays for further understanding of BosR 
function. Our preliminary findings suggest that BosR is post-transcriptionally regulated 
by an unknown protease and may not need to bind to any rpoS upstream regions in order 
to activate transcription. We also describe the construction of luciferase reporter systems 
that will shed light on BosR’s mechanism of action. We postulate the provocative 
possibility that unlike its homologs Fur and PerR in other bacterial systems, BosR may 
not utilize a DNA-binding mechanism in order to fulfill its role as a 
transcriptional regulator to modulate virulence gene expression.  
 
X. Frank Yang, Ph.D, Chair  
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INTRODUCTION 
Borrelia burgdorferi, the deer tick and the accidental host 
Lyme disease is the most common arthropod-borne disease in the United States of 
America. Statistics published by the Centers for Disease Control and Prevention (CDC) 
show that the number of confirmed cases have been on a general upward trend since 
1992, when 9,908 cases were reported, to 2011, when 24,364 cases were reported. Most 
of the cases tend to be concentrated in the Northeast and North Central regions although 
it must be noted that the cases are reported by county of residence, not county of 
infection (Bacon et al., 2008; CDC, 2012). Lyme disease was first characterized in 1977 
when cases of juvenile rheumatoid arthritis inflicting both adults as well as children in 
three communities were reported (Steere et al., 1977) and subsequently found to correlate 
with the presence of the deer tick, Ixodes scapularis, also known as Ixodes dammini 
(Steere et al., 1978). Later, the causative agent was isolated from its tick vector and 
determined to be a new species of gram-negative spirochetal bacteria (Burgdorfer et al., 
1982; Steere et al., 1983) and subsequently named Borrelia burgdorferi (Johnson et al., 
1984). The early symptoms of Lyme disease include influenza-like symptoms such as 
fever, fatigue, chills and headaches, as well as erythema migrans, a characteristic bulls-
eye rash at the site of the tick bite that is a hallmark of the disease. Antibiotics are 
generally effective first line treatments in this early stage although there are cases in 
which persistent infection occurs. Unfortunately, not all cases present with erythema 
migrans, making Lyme disease difficult to diagnose since the disease shares symptoms 
with other more common diseases. Left untreated, it can progress to debilitating 
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symptoms such as Bell’s palsy, meningitis, arrhythmia and chronic arthritis (Schoen, 
1991; Burgdorfer, 1991; Cooke and Dattwyler, 1992; Steere, 2001; Wright, 2012).  
Despite rising awareness about Lyme borreliosis and its danger to public health, a 
United States Food and Drug Administration (FDA)-approved recombinant vaccine 
received poor public response. The vaccine prevented transmission of B. burgdorferi 
from ticks to humans. It was made available to the public in December 1998 but was 
discontinued in February 2002. Among the suggested reasons for the bad reception of the 
vaccine were cost effectiveness, the need for multiple booster shots and questions about 
the possibility of autoimmune reaction (Hayes and Piesman, 2003; Clark and Hu, 2008; 
Embers and Narasimhan, 2013). Current recommended preventive measures include 
avoidance of ticks, the use of tick repellant, the use of protective clothing, vegetation 
removal at high-risk residential areas, or sometimes antimicrobial prophylaxis (Poland, 
2001; Hayes and Piesman, 2003; Wormser et al., 2006; Vazquez et al., 2008; Clark and 
Hu, 2008).  
In the years since its discovery, the enzootic life cycle of B. burgdorferi has been 
well-studied, as depicted in Figure 1. The spirochete is transmitted when uninfected deer 
tick larvae feed on small infected mammals such as mice. The fed larva then molts into 
an infected nymph which feeds on other (uninfected) mammals, thereby perpetuating the 
transmission cycle. It is usually in this nymphal stage that humans become inadvertent 
hosts because the seasonal appearance of blood-seeking nymphs from May to July 
coincides with the peak of human summer outdoor activities in July. It is interesting to 
note that the white-tailed deer, Odocoileus virginianus, has been linked to the 
maintenance of B. burgdorferi in nature even though it is apparently resistant to infection 
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by the spirochete. It appears that the deer is simply an important host for I. scapularis 
adults, whereas it is the white-footed mouse, Peromyscus leucopus, which has been 
shown to be the natural reservoir of B. burgdorferi. However, other small- and medium-
sized mammals such as birds, squirrels, chipmunks, raccoons and opossums can also 
maintain the spirochetes and are hosts to questing deer ticks (Lane et al., 1991; Fish, 
1995; Clark and Hu, 2008; Radolf et al., 2012). The molecular mechanisms behind the 
fastidious spirochete’s ability to adapt to two very distinct environments have been 
rigorously studied but much remains to be understood in order to eradicate the 
debilitating disease associated with it. 
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Figure 1. The life cycle of Borrelia burgdorferi and its relation to human infection. 
Larval and nymphal ticks tend to feed on small- to medium-sized mammals, whereas 
adults generally prefer large mammals such as deer and also carry out their sexual 
reproduction on the large hosts (Radolf et al., 2012). 
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Reciprocal regulation of major membrane lipoproteins 
It has been shown that B. burgdorferi’s aptitude at surviving so proficiently when 
moving between invertebrate vector and vertebrate host relies on differential expression 
of two major outer membrane lipoproteins, outer surface protein A (OspA) and outer 
surface protein C (OspC). Several groups have observed that OspA is expressed in unfed 
nymphal ticks whereas OspC is virtually undetectable, but OspA is downregulated during 
nymphal tick feeding whereas OspC is upregulated (Schwan et al., 1995; Montgomery et 
al., 1996; de Silva et al., 1996; Schwan and Piesman, 2000; Gilmore and Piesman, 2000; 
Fingerle et al., 2002). Figure 2 illustrates the reciprocal regulation of OspA and OspC in 
the B. burgdorferi transmission cycle (Mulay et al., 2009). This reciprocal regulation can 
be mimicked in the laboratory by incubating Borrelia cultures in different temperatures—
at 23°C, OspA is upregulated whereas OspC is virtually undetectable, and at 37°C, OspC 
is upregulated whereas OspA is downregulated (Schwan et al., 1995; Yang et al., 2000). 
Naturally, the next step was for investigators to elucidate the molecular mechanism 
behind this important differential gene expression. A breakthrough came when the 
Norgard group showed that OspC was controlled by the alternative sigma factor RpoS 
(S or 38), which was in turn controlled by another alternative sigma factor, RpoN (N 
or 54) (Yang et al., 2000; Hübner et al., 2001; Yang et al., 2003a). OspA was 
subsequently shown to be required for tick infection (Yang et al., 2004; Pal et al., 2004b) 
and conversely, OspC was required for mammalian infection (Grimm et al., 2004; Pal et 
al., 2004a). 
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The Rrp2-RpoN-RpoS pathway 
Sigma factors accord specificity to what would otherwise be indiscriminate and 
weak gene transcription by bacterial RNA polymerase (RNAP). Sigma factors are 
divided into the 70 family and the 54 family. RpoN (N or 54) and its orthologs are the 
only members of the 54 family whereas all the other sigma factors are lumped into the 
70 family. While the 70 family sigma factors recognize canonical -35/-10 promoter 
sequences, 54 recognizes a unique promoter with conserved GG and GC sequences at 
the -24 and -12 regions respectively. The number of sigma factors from the 70 family 
varies according to the microbe (for example, Streptomyces coelicolor has 63 whereas 
Escherichia coli has six), but microbes tend to only have one 54-type sigma factor, if 
any at all. RNAPs are composed of the subunits α2ββ′ω and it is the β and β’ subunits that 
form an association with a sigma factor to create the functional RNAP holoenzyme 
(Merrick, 1993; Barrios et al., 1999; Buck, et al., 2000; Studholme and Buck, 2000b; 
Gruber and Gross, 2003; Ghosh et al., 2010; Österberg et al., 2011; Bush and Matthew, 
2012; Lee et al., 2012).  
Based on B. burgdorferi’s published full genomic sequence, it appears that 
besides RpoD (70, known also as the “housekeeping” sigma factor because of its role in 
transcription initiation of most genes in all bacteria), the spirochete encodes only two 
alternative sigma factors in its genome—RpoS and RpoN (Fraser et al., 1997). RpoS is a 
widely distributed sigma factor associated with stress adaptation in other pathogenic 
bacteria such as E. coli (Hengge-Aronis, 1993), Salmonella spp. (Fang et al., 1992), and 
Pseudomonas aeruginosa (Suh et al., 1999) but variably associated with virulence (Dong 
and Schellhorn, 2010). As such, it was assumed that RpoS would follow a similar pattern 
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in B. burgdorferi and regulate the general stress response but this was disproved by the 
Radolf group when they found that RpoS was not essential in spirochete survival during 
environmental stresses (Caimano et al., 2004). However, they and the Norgard group did 
find that RpoS controls other genes that are required for virulence such as OspC and 
decorin binding protein A (DbpA) and was essential for mammalian infection, being 
upregulated in mice but downregulated in ticks (Figure 2) (Yang et al., 2000; Hübner et 
al., 2001; Yang et al., 2003; Caimano et al., 2004; Fisher et al., 2005; Yang et al., 2005; 
Samuels, 2011). It was shown that RpoS expression in mammals and ticks could be 
mimicked in vitro, with growth at 23°C mirroring tick conditions and growth at 37°C 
mirroring mammalian conditions (Yang et al., 2000).  
The other sigma factor encoded in the B. burgdorferi genome, RpoN, is also 
commonly found in other gram-negative pathogens such as E. coli, P. aeruginosa and 
Helicobacter pylori, where it has been implicated in the control of several pathways 
including nitrogen assimilation (for which the ‘N’ in RpoN and N stand for), formate 
metabolism and flagellin synthesis (Totten et al., 1990; Merrick, 1993; Reitzer and 
Schneider, 2001; Smith et al., 2009). RpoN’s singular trademark of recognizing -24/-12 
promoter sequences instead of the usual -35/-10 clued the Norgard group in on the novel 
possibility of RpoN-dependent transcription of rpoS when a study reported the possible 
presence of the -24/-12 consensus sequence immediately upstream of the rpoS gene in B. 
burgdorferi (Studholme and Buck, 2000a). The Norgard group subsequently showed that 
not only was rpoS transcription dependent on RpoN, it was also directly controlled by 
RpoN (Smith et al., 2007; Burtnick et al., 2007). To date, evidence of RpoN-dependent 
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RpoS transcription has only been published for B. burgdorferi and no other bacterial 
system.  
Unlike the 70 family, RpoN requires the aid of an enhancer-binding protein 
(EBP) with ATPase activity in order to initiate gene transcription. RpoN-dependent EBPs 
generally bind relatively far upstream (85-150 bp) of the transcriptional start site causing 
DNA to loop and isomerizing the closed complex of DNA bound to the RpoN-RNA 
polymerase holoenzyme into an open complex (Merrick, 1993; Morett and Segovia, 
1993; Buck, et al., 2000; Gruber and Gross, 2003; Österberg et al., 2011; Shingler, 2011). 
Accordingly, the work of Yang et al. pointed to Rrp2, one of only two putative two-
component response regulators and the only predicted EBP in B. burgdorferi (Yang et al., 
2003b; Fraser et al., 1997), as the RpoN-dependent EBP activating the RpoN-RpoS 
pathway. The Gherardini group corroborated the finding, but reported the unexpected 
discovery that Rrp2 did not appear to require binding to predicted enhancer sequences 
upstream of RpoN-dependent genes in order to initiate transcription. Figure 3a illustrates 
their proposed pathway model (Burtnick et al., 2007). Blevins et al. confirmed the 
results, finding that B. burgdorferi mutants with a minimal RpoN-dependent rpoS 
promoter that did not include the predicted enhancer elements were enough to cause 
infectivity in mice (Blevins et al., 2009). 
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Figure 2. Differential expression of OspA and OspC in a reciprocal manner 
corresponding to RpoS expression pattern (Samuels, 2011). BBA74 and OspE are not 
addressed in this dissertation. 
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BosR, another activator of the Rrp2-RpoN-RpoS pathway 
B. burgdorferi further confounded researchers when they discovered that not only 
did the spirochete possess an EBP with unorthodox qualities in Rrp2, it now appeared 
that there was also a second transcriptional activator for the same novel pathway 
activated by Rrp2. Although BB0647—known as BosR for Borrelia oxidative stress 
regulator protein—has been scrutinized as far back as 2003 (Boylan et al., 2003), it was 
not until 2009 and 2010 that the Norgard and Skare groups drew a possible link between 
BosR and the Rrp2-RpoN-RpoS pathway in two separate papers. The Skare group saw 
that the increased expression of OspC and decorin binding protein A (DbpA) correlated 
with the increased expression of BosR in their IPTG-induced conditional mutant (Hyde et 
al., 2010). The Norgard group reported a similar result with their bosR deletion strain and 
further found that RpoS was also abrogated in the absence of BosR.  Importantly, they 
also discovered that BosR is required for transmission and infectivity in mice and that the 
absence of BosR correlated with the absence of RpoS, but not of Rrp2 (Ouyang et al., 
2009).  
BosR was initially designated as ferric uptake regulation protein (Fur) homolog 
when the full B. burgdorferi annotated genome was published (Fraser et al., 1997). 
However, a study published in 2000 challenged the naming of the protein when it 
suggested that B. burgdorferi does not require iron, one of the very few microbes to 
possess that trait (Posey and Gherardini, 2000; Andrews et al., 2003). It is well-
documented that Fur and its homologs have been found in a wide variety of gram-
negative as well as gram-positive bacterial species, most notably in pathogenic species 
such as Salmonella typhimurium, Yersinia pestis and Listeria monocytogenes. As its 
13 
 
name suggests, Fur controls iron homeostasis but it also functions as a global regulator of 
genes that are both iron-related and non-iron-related such as genes involved in flagellum 
assembly and colonization (Escolar et al., 1999; Carpenter et al., 2009). The Gherardini 
group published the first study on BB0647, suggesting that it appeared to be more similar 
to the peroxide stress response regulator (PerR), a member of the Fur family of 
transcriptional regulator proteins, in Bacillus subtilis based on a 50.7% sequence 
homology, but found that it did not share the same functions. They proposed that while 
PerR is a transcriptional repressor, it appeared that its B. burgdorferi homolog is a 
transcriptional activator, and thereafter named the protein BosR. They found that BosR 
activates transcription of napA which is an oxidative stress regulator gene (Boylan et al., 
2003). However, Katona et al referred to BosR as Fur in their 2004 paper, and argued 
that it functioned as a repressor when exposed to peroxide stress.  
Using in vitro DNA footprinting studies, Ouyang et al. suggested that BosR binds 
to three regions very close to the rpoS promoter which they termed Binding Site (BS) 1, 
BS2 and BS3. The rpoS -24/-12 promoter (PrpoS) is part of the BS2 sequence (Figure 
3c). It appeared that BosR bound with much higher affinity to BS2 compared to BS1 and 
BS3 and that there was a consensus sequence of TAAATTAAAT in BS2, similar to the 
AT-rich consensus sequences of Fur and PerR-binding boxes (Ouyang et al., 2011). 
However, prior to that study, Blevins et al. had indirectly shown that BS1 and the 
TAAATTAAAT portion of BS2 directly in front of PrpoS (Figure 3c) are not required for 
BosR-induction of rpoS transcription because BS3 together with what was left of BS2 
was sufficient to rescue RpoS protein expression as well as the expression of two RpoS-
dependent proteins, OspC and DbpA, in an rpoS deletion mutant of B. burgdorferi  
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(rpoS-, Lane 2) as seen in Figure 4, albeit with decreased levels as compared to wild-type 
strain 297 (Lane 1) (Blevins et al., 2009). Nonetheless, the minimal Prpos-complemented 
mutant strain (rpoS-/pJSB298, Lane 4) displayed similar protein expression levels as the 
fully-complemented mutant strain (rpoS-/pJSB259, Lane 3), suggesting that the decrease 
was probably due to other factors such as transcriptional stability. Importantly, the rpoS 
deletion strain complemented with a minimal PrpoS containing a point mutation in the -
24/-12 region (Lane 5) could not rescue the expression of the three proteins. Ouyang et al 
themselves remarked that their finding of BosR binding tightest to BS2 as compared to 
BS1 and BS3 could be “physiologically irrelevant.” It must be pointed out that BS3 was 
intact in the Blevins et al complement strains, implying a compensatory role or even that 
BS3 is the most relevant physiological BosR binding site. Interestingly, BS3 is located 
downstream of the rpoS transcriptional start site which is highly unusual in the bacterial 
world since transcriptional regulators generally bind to upstream regions. However, there 
have been certain exceptions to this rule such as that of the transcriptional activator RutR 
in E. coli (Shimada et al., 2008) and that of an unidentified regulator in Azotobacter 
vinelandii (Mitra et al., 2005). BosR’s mode of action still remains to be elucidated 
especially in vivo although a proposed model of rpoS transcription is shown in Figure 3b 
(Burtnick et al., 2007). 
An intriguing new possible trait of BosR came to light fairly recently when an 
unpublished study by Haijun Xu, a postdoctoral researcher in the Yang lab, revealed that 
although the expression of BosR protein in cultured B. burgdorferi mimicked the 
differential regulation of tick and mammalian conditions, it appeared that its mRNA 
levels were similar in both conditions, indicating that there may be regulation of BosR at 
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a post-transcriptional level (Xu and Yang, unpublished data). This led us to hypothesize 
that a protease could be involved in the regulation of BosR, a suggestion again as-yet 
unseen in other bacteria, assuming the homology of BosR to Fur and PerR hints at 
functional and regulatory similarities. Although both Fur and PerR are acknowledged as 
important transcriptional regulators and are essential for virulence in some bacteria such 
as P. aeruginosa, Staphylococcus aureus, Listeria monocytogenes and Vibrio cholerae 
(Escolar et al., 1999; Horsburgh et al., 2001; Rea et al., 2004; Carpenter et al., 2009), 
very little research has been done on the regulation of the two proteins themselves.  
What little is currently known suggests that Fur and PerR can auto-regulate their 
gene expression in microbes such as Campylobacter jejuni and Vibrio vulnificus (Chan et 
al., 1995; Lee et al., 2003; Lee et al., 2007), and Fur is regulated by RpoS in V. vulnificus 
(Lee et al., 2003) and may be reciprocally regulated in E. coli with the Crl protein 
(Lelong et al., 2007). Since mRNA levels of bosR at room temperature and 37°C cultures 
are similar, it appears unlikely that bosR is regulated at the transcriptional level. Since 
BosR is required for the activation of the Rrp2-RpoN-RpoS pathway, it is also unlikely 
that RpoS regulates the expression of BosR. Because of these observations, our focus 
shifted to exploring the regulation of BosR. We theorized that BosR is post-
transcriptionally regulated by a protease. 
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Figure 3. Proposed model of Rrp2-RpoN-RpoS pathway (a) before and (b) after the in 
vitro characterization of BosR’s role in the pathway (Burtnick et al., 2007). (c) Sequence 
of Ouyang et al.’s proposed BosR binding sites on PrpoS (Ouyang et al., 2011). The 
dotted line boxes denote binding sites 1, 2 and 3 (BS1, BS2 and BS3) and the underlined 
sequences are the proposed binding sequences. The -24/-12 sequence as well as the 
translational start site (ATG) are in bolded font, and the transcriptional start site is 
marked with an asterisk (*). 
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Figure 4. Upper panel shows a Coomassie stain of sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) with the OspC band pointed out and 
lower panel shows a Western immunoblot with FlaB as loading control. 297 is a wild-
type B. burgdorferi strain, rpoS- is an rpoS deletion mutant strain, rpoS-/pJSB259 is an 
rpoS- strain fully complemented with the rpoS gene and an upstream region that includes 
BS1, BS2 and BS3, rpoS-/pJSB296 is a partially complemented strain that contains the 
rpoS gene complement with an upstream region that includes BS3 and BS2 but with the 
TAAATTAAAT sequence and rpoS-/pJSB298 is a minimal rpoS- promoter-
complemented strain with a point mutation in the promoter sequence. All 
complementation was done via transformation with shuttle vectors (Blevins et al., 2009). 
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MATERIALS AND METHODS 
Bacterial strains and culture conditions 
The strains of B. burgdorferi used were wild-type strain B31-MI and OY10/H3, a 
bosR deletion strain provided by Zhiming Ouyang (Ouyang et al., 2009), which was 
derived from parental strain B31-MI. B31-MI has no antibiotic marker whereas OY10/H3 
has a kanamycin resistance marker.  The spirochetes were grown in BSK-Y medium 
(Table 1 and Pollack et al., 1993), either at room temperature or 37°C. E. coli strain 
Rosetta™ BL21 (DE3) pLysS Competent Cells (Novagen, Billerica, MA) was grown in a 
medium containing 0.5x Difco™ LB Broth, Miller (Luria-Bertani) from BD Diagnostics 
(Sparks, MD), 0.5x phosphate-buffered saline (PBS) (Table 1), 0.2% glucose and 35 
µg/mL chloramphenicol at 37°C with vigorous shaking.  
 
Plasmid DNA purification 
We used the QIAGEN (Valencia, CA) Plasmid Mini Kit or Sigma-Aldrich (St. 
Loius, MO) GenElute
™
 Plasmid Maxiprep Kit, depending on the amount of DNA 
required and bacterial culture volume, as per manufacturer’s instructions. The 
concentration and purity of isolated DNA was determined using the NanoDrop 2000c 
from Thermo Scientific (Wilmington, DE).  
 
RNA purification 
 B. burgdorferi cells were grown to stationary phase and 5 x 10
8
 spirochetes were 
then collected by centrifugation at 5,000 x g, 4°C, 20 minutes. The cells were washed 
once in 0.9% (w/v) sodium chloride before being lysed in 1 mL TRIzol
®
 Reagent 
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(Invitrogen, Grand Island, NY) with repeated pipetting and incubation at room 
temperature for five minutes to allow for complete dissociation of nucleoprotein 
complexes. Chloroform was added in a 1:5 ratio of chloroform to TRIzol
®
 Reagent and 
after vigorous shaking, the mixture was centrifuged at the following conditions: 8,000 x 
g, 4°C, 15 minutes. After a two to three minute incubation at room temperature, the 
aqueous phase was saved and the following steps were adapted based on the protocol 
provided by QIAGEN in their RNeasy Mini Kit, and all centrifugation was done at 8,000 
x g and room temperature. A roughly equivolume amount of 70% ethanol was added with 
vortexing before transfer to an RNeasy Mini spin column and centrifugation for one 
minute. After a wash with Buffer RW1, 10 µL of DNase I (New England Biolabs, 
Ipswich, MA) in 70 µL Buffer RDD was added directly onto the spin column membrane 
and incubated for 15 minutes at room temperature. The Buffer RW1 wash step was then 
repeated and another two wash steps using Buffer RPE were performed. After drying the 
membrane via a one minute centrifugation, the RNA was eluted using RNase-free double 
distilled water and the concentration and purity were determined using a NanoDrop 
2000c (Thermo Scientific). 
 
 
Polymerase chain reaction (PCR) 
 Single-stranded cDNA was reverse transcribed from purified RNA using the 
ThermoScript™ RT-PCR System for First-Strand cDNA Synthesis System (Invitrogen) 
as per the manufacturer’s protocol. PCR with double-stranded cDNA as the end product 
were carried out with Phusion® High-Fidelity PCR Kit (Thermo Scientific) based on kit 
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instructions at a temperature roughly in between the melting temperatures of the forward 
and reverse primers. Quantitative PCR (qPCR) was done using RT
2
 SYBR® Green PCR 
Master Mix (New England Biolabs), according to the supplied manual. The machines 
used were MyCycler™ Personal Thermal Cycler (Bio-Rad, Hercules, CA) and for qPCR, 
ABI Prism 7000 Sequence Detector (Applied Biosystems, Grand Island, NY). 
 
SDS-PAGE and Western blot 
 For sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
samples were diluted 1:1 with Laemmli Sample Buffer (Bio-Rad) and boiled for 10 
minutes then electrophoresed using 12% Mini-PROTEAN® TGX™ Precast Gel (Bio-
Rad) in Running Buffer at 7mA constant current per gel for 45 minutes then 20mA per 
gel for 90 minutes. The gel was then stained with Coomassie Dye Solution overnight and 
destained with Destaining Solution overnight. For immunoblotting, the gel was not 
stained with Coomassie blue. A piece of nitrocellulose membrane (Bio-Rad) with 0.2µM 
pores and Transfer Buffer were used for the immunoblot which was run at 80V and 4°C 
for two hours. The membrane was blocked with PBS-Tween for 30 minutes before 
overnight incubation with primary mouse polyclonal antibody. Excess primary antibody 
was then rinsed off twice with 1x PBS-Tween for five minutes each time and goat anti-
mouse immunoglobulin G (secondary antibody) was added. The membrane was 
incubated with secondary antibody for three to four hours then rinsed with Tris-NaCl (pH 
7.6) twice for ten minutes each time. The dilutions of antibodies used were 1:4000 
dilution of BosR antibody, 1:50 dilution of FlaB antibody (loading control) and 1:1000 
dilution of secondary antibody. Developing solution was added to the membrane and 
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when bands were visualized, the reaction was stopped with distilled water. All antibody 
incubation, rinse and membrane development steps were done at 4°C on a rocker to 
prevent protein degradation as well as localized reactions. Table 1 details the exact 
composition of all reagents used. 
 
Generation of B. burgdorferi cell-free extract 
We generated cell-free extract (CFE) from 4 x 10
10
 B31-MI cells grown to 
stationary phase in BSK-Y medium at room temperature (RT-CFE) and 37°C (37-CFE). 
We centrifuged the cells at 5,000 x g for 20 minutes at 4°C, washing three times with 
sterile Potassium Phosphate Buffer (KP) (Table 1). On the last wash, we concentrated the 
spirochetes in fresh KP 1000-fold from the original culture volume. Bacterial suspensions 
were aliquoted into Lysing Matrix B tubes (MP Biomedicals, Solon, OH) – which have 
beads that are specialized for tissue or cell homogenization – then mounted in a 
FastPrep®-24 instrument (MP Biomedicals). The machine was run at its lowest setting 
for ten seconds, after which the tubes were allowed to rest for five minutes on ice. This 
step was repeated at least five times before centrifuging the tubes at highest speed for 20 
minutes at 4°C. The supernatant, which was the cell-free extract (CFE), was saved and 
stored at -80°C. 
 
Purification of recombinant BosR 
We purified recombinant BosR (rBosR) from E. coli using a technique adapted 
from Ouyang et al. in their 2009b paper. Plasmid pOY21, generously provided by 
Zhiming Ouyang, was transformed into E. coli strain Rosetta™ BL21 (DE3) (Novagen). 
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The pOY21 plasmid contained the bosR gene in a pPROEX-HTB vector, and the 
resulting protein is His6-tagged at the N-terminus. The pPROEX-HTB vector has an 
ampicillin-resistance gene so accordingly, 135 µg/mL of ampicillin was added to the 
growth medium described in the earlier section on bacterial culture conditions. After 1 
mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) induction of protein expression, 
BosR was purified using the Ni-NTA Agarose resin system from QIAGEN using a 
protocol adapted from the manufacturer’s instructions. Two hours after IPTG induction, 
the E. coli cells were pelleted at 5,000 x g for 15 minutes at 4°C. The supernatant was 
discarded and the cells were resuspended in Buffer A at a 1:100 ratio compared to the 
original volume of the cell culture. 17.4 µg/mL phenylmethanesulfonylfluoride (PMSF), 
a serine protease inhibitor, was added to the suspension and the bacterial cells were then 
lysed using the FastPrep®-24 instrument (MP Biomedicals) as described in the preceding 
section. A slim glass column was capped at the bottom with a rubber cork containing a 
flexible capillary tube. The tube was then filled with Ni-NTA Agarose (QIAGEN) and 
the beads were allowed to settle and compact. CFE from the lysis step was added to the 
Ni-NTA column and the flow-through collected in 2-3 mL fractions.  Recombinant BosR 
was then eluted using 15 mL each of solutions 1, 2 and 3 which were added 
consecutively and also collected in fractions of 2-3 mL. 50 µL of each fraction was taken 
for SDS-PAGE to determine which contained the purified rBosR. Those fractions were 
mixed together in a 50 mm flat width regenerated cellulose dialysis tube (Fisherbrand, 
Pittsburgh, PA) and put into 4 L of storage buffer together with a magnetic stirrer set at 
high speed for 6 hours. The storage buffer was then discarded and the dialysis repeated 
for another 12 hours. The Ni-NTA elution and subsequent dialysis were carried out at 
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4°C. The dialyzed rBosR was analyzed using SDS-PAGE to check its purity and the 
protein was stored at -80°C. The exact composition of the buffers and solutions used are 
detailed in Table 1. 
 
Determination of protein concentration 
We ascertained the protein concentration of the CFEs using the Coomassie 
(Bradford) Protein Assay Reagent from Thermo Scientific according to manufacturer’s 
instructions. Firstly, 30 µL each of CFE and bovine serum albumin (BSA) solutions of 
known concentrations (0.1 g/mL, 0.25 g/mL, 0.5 g/mL and 1.0 g/mL) were added to 1.5 
mL of room temperature reagent respectively and light absorbance at 595 nm was 
determined using an Evolution 160 UV-Vis Spectrophotometer (Thermo Scientific). A 
standard curve of absorbance versus BSA concentration was then plotted and the protein 
concentration of the CFE was determined based on the curve. If the light absorbance of 
the CFE was higher than the light absorbance of the highest concentration of BSA, 15 µL 
or 3 µL of CFE was used for the assay instead, and protein concentration calculated 
accordingly. 
 
Protein degradation assay 
Recombinant BosR was incubated with RT-CFE and 37-CFE at room temperature 
using a 1:100 ratio of protein to CFE, and the mixture was analyzed at several time points 
using Western blot technique. The time points were: immediately after mixing rBosR 
with CFE, and 2 hours, 4 hours, 6 hours, 12 hours, 24 hours and 48 hours after mixing. It 
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is important to note that the amount of rBosR used in the experiment is very likely much 
higher than physiologically seen in B. burgdorferi.   
 
Construction of luciferase reporter plasmids 
 We began with pJD48, a promoterless luciferase reporter plasmid that contains a 
kanamycin resistance marker (Blevins et al., 2007). The kanamycin resistance marker 
was replaced with a gentamycin resistance gene via restriction digests and ligations. The 
replacement was done because B. burgdorferi strain OY10/H3 contains a kanamycin 
resistance marker and hence electrotransformation with reporter plasmids containing the 
same marker prevents selection for true transformants. Desired DNA fragments were 
inserted also using restriction digests and ligations. Restriction digest enzymes and buffer 
were bought from Fermentas (Vilnius, Lithuania) whereas ligase enzymes and buffer 
were from Promega (Madison, WI). The protocols used were provided by manufacturers. 
The inserts from Figure 5b and Figure 5c were cut from a plasmid that contained the 
desired product (Haijun Xu, unpublished data) and the insert from Figure 5d was cloned 
using B. burgdorferi B31-MI template DNA whereas the inserts from Figure 5e and 
Figure 5f  were cloned with E. coli TOP10 DNA as a template. The primers used in the 
cloning are detailed in Table 2. 
 
Electrotransformation of B. burgdorferi 
 We adapted our protocol from Hyde et al.’s 2005 paper. For every sample to be 
transformed, a stationary phase culture of 7.5 x 10
9
 spirochetes was washed twice with 
0.9% (w/v) sodium chloride and three times with Electroporation Solution (EPS) (Table 
1). For each wash step, 8 mL of solution was used and the cells were centrifuged at 4,000 
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x g to 5000 x g for 20 minutes at 4°C. After the final wash step, the cells were 
resuspended in 50 µL of EPS buffer and incubated on ice for 1 minute with 20 µg of the 
desired plasmid DNA in a 0.2 cm electroporation cuvette (Bio-Rad Gene Pulser). The 
mixture was then electroporated using Gene Pulser Xcell™ Microbial System (Bio-Rad) 
at 2.5 kV, 25 µF and 200 e at a time constant of between 4 and 6 milliseconds. 
Immediately after electroporation, 1 mL of BSK-Y was added before transfer into 
another 35 mL of BSK-Y. After overnight incubation at 37°C, antibiotics (0.4 mg/mL 
gentamycin and 1 mg/mL kanamycin, as appropriate) and 600 µL of phenol red (for 
stronger medium color visualization) were added. Aliquots of 180 µL of the culture were 
placed into a 96-well cell culture plate. The plate was then incubated at 37°C and 
observed over a period of seven to 14 days. A change in color of the medium from red to 
yellow indicated bacterial cell proliferation (positive clones), which was verified using 
dark-field microscopy. Wells identified as having growing borrelial cells were sub-
cultured in a 1:5,000 ratio of culture to fresh media containing appropriate antibiotics and 
when cell growth reached stationary phase, plasmid DNA was harvested to determine 
true transformants.  
 
Confirmation of true Borrelia transformant clones 
 The tests we conducted were chemical transformation of E. coli and DNA 
sequencing of the plasmid DNA isolated from successful E. coli transformants, using 
appropriate primers flanking the desired gene. Plasmid DNA isolated from B. burgdorferi 
transformant clones were chemically transformed into E. coli TOP10 calcium chloride-
treated competent cells using a well-known 42°C heat-shock method. 
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Chemotransformation of E. coli with pure plasmid DNA diluted to the same 
concentration as the DNA purified from B. burgdorferi served as a positive control. E. 
coli chemotransformation of plasmid DNA from true B. burgdorferi transformants 
produces a similar number of colonies to E. coli transformed with pure plasmid DNA.  
For those that passed the test, plasmid DNA was isolated from the E. coli hosts and 
subjected to sequence confirmation at the DNA Sequencing Core Facility of Indiana 
Univesity. The chemical transformation of E. coli was used as an additional confirmation 
step.  
 
Luciferase reporter assay 
 Approximately 1 x 10
9
 spirochetes grown to stationary phase were used for each 
reaction. The cells were washed twice with sterile 0.9% NaCl solution at 5,000 x g, 10 
minutes, 4°C. The cells were then lysed with vigorous vortexing in a solution containing 
1x Cell Culture Lysis Reagent (Promega) and 0.125% lysozyme from chicken egg white 
(USB, Cleveland, OH), and supplemented with 5 mg/mL BSA (Blevins et al., 2007). 
Luciferase Assay Reagent (Promega) and the measurement of light produced was carried 
out using Promega’s protocol for single-tube luminometers on a TD-20/20 Luminometer 
(Turner Design, Sunnyvale, CA). 
 
  
29 
 
Page(s) Reagent Component Concentration 
20 Barbour-Stoenner-Kelly medium 
(BSK-Y) (pH 7.5, filtered using 0.2µM 
Millipore Stericup® or Corning® 
vacuum filtration systems) 
HEPES 25.2 mM 
  Bacto™ Neopeptone (BD) 0.5% (w/v) 
  D-(+)-Glucose 27.8 mM 
  Sodium pyruvate 7.3 mM 
  Sodium citrate 0.07% (w/v) 
  Bacto™ TC Yeastolate (BD) 0.25% (w/v) 
  N-acetylglucosamine 1.8 mM 
  Sodium bicarbonate 26.2 Mm 
  Probumin, universal grade (Millipore) 5% (w/v) 
  CMRL 1066 (US Biological) 0.98% (w/v) 
  Rabbit serum, heat inactivated at 56°C for 
45 minutes (Equi-tech, Inc) 6.4% (v/v) 
20 1x Phosphate-buffered saline (PBS) 
(pH 7.4) 
Sodium chloride 137 mM 
  Potassium chloride 2.7 mM 
  Sodium phosphate, dibasic 10 mM 
  Potassium  phosphate, monobasic 1.8 mM 
22 Running Buffer Sodium dodecyl sulfate (SDS) 3.5 mM 
    Tris-base 25 mM 
    Glycine 192 mM 
22 Coomassie Dye Solution Coomassie Brilliant Blue R-250 0.86 mM 
    Glacial acetic acid 14.3% (v/v) 
    Methanol 14.3% (v/v) 
22 Destaining Solution Glacial acetic acid 10% (v/v) 
  Methanol 10% (v/v) 
Continued on Page 30 
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22, 23 Transfer Buffer Glycine 38.7 mM 
  Tris base 23.1 mM 
  Methanol 20 % (v/v) 
23 PBS-Tween 1x PBS 99.5% (v/v) 
  Tween-20 0.5% (v/v) 
23 Tris-NaCl (pH 7.6) Tris base 50 mM 
  NaCl 200 mM 
23 Developing Solution (Tris-NaCl was the 
solvent used) 
4-chloro-1-naphthol in methanol, 16.8 mM 16.67% (v/v) 
  Hydrogen peroxide 0.1% (v/v) 
24 Buffer A Sodium phosphate, dibasic 20 mM 
  Sodium phosphate, monobasic 20 mM 
  NaCl 200 mM 
  β-mercaptoethanol 100 µM 
N/A Buffer B Sodium phosphate, dibasic 10 mM 
  Sodium phosphate, monobasic 10 mM 
  NaCl 100 mM 
  β-mercaptoethanol 50 µM 
  Imidazole 200 mM 
25 Solution 1 Buffer A 98% (v/v) 
  Buffer B 2% (v/v) 
  Imidazole 20 mM 
25 Solution 2 Buffer A 90% (v/v) 
  Buffer B 10% (v/v) 
  Imidazole 50 mM 
Continued on Page 31 
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25 Solution 3 Buffer B 85% (v/v) 
  Imidazole 500 mM 
25 Storage Buffer (pH 7.8) Potassium phosphate, dibasic 45 mM 
  Potassium phosphate, monobasic 5 mM 
  Ethylenediaminetetraacetic acid (EDTA) 0.1 mM 
  Glycerol 35% (v/v) 
25 Potassium Phosphate Buffer (pH 7.8) Potassium phosphate, dibasic 45.5 mM 
  Potassium phosphate, monobasic 4.5 mM 
27 Electroporation Solution (EPS) (filtered 
using 0.2µM Millipore Stericup® or 
Corning® vacuum filtration systems) 
Sucrose 271.7 mM 
  Glycerol 15% (v/v) 
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Table 1. Composition of reagents used in our studies. All reagents used double distilled water as a solvent, unless otherwise stated.  
3
2
 
33 
 
 
  
TTTTAAATTAAATTGGCACAGTTTTTGCATGGAAATTAAGTAGTAAAAAC 
 
 
TTAATCACAATATTCAAGAAAGGGGAGAAAATATAATAACTATG luc 
Bb min BS2 Bb rpoS -24/-12 
SD 
TTTTAAATTAAATTGGCACAGTTTTTGCATGGAAATTAAGTAAGGATTTGC 
 
 
CAAAGTCAGAAATTTAAATTTTATCATGGAGGAATGATAT ATG luc 
Bb min BS2 Bb rpoS -24/-12 
SD 
TTTTGGCACAGTTTTTGCATGGAAATTAAGTAGTAAAAAC 
 
 
TTAATCACAATATTCAAGAAAGGGGAGAAAATATAATAACTATG luc 
Bb rpoS -24/-12 
SD 
TTTTGGCACAGTTTTTGCATTATCTTTTTTACGGCGACACGGCCAAAATAATTGCA 
 
 
GATTTCGTTACCACGACGACCATGACCAATCCAGGAGAGTTAAAGTATG luc 
Bb rpoS -24/-12 
SD 
TTTTGGCACAGATTTCGCTTTATCTTTTTTACGGCGACACGGCCAAAATAATTGCA 
 
 
GATTTCGTTACCACGACGACCATGACCAATCCAGGAGAGTTAAAGTATG luc 
Ec glnALG -24/-12 
SD 
3
3
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Figure 5. Illustrations and sequences of various promoter elements fused to luciferase reporter plasmid shuttle vectors. Bb refers to B. 
burgdorferi, min BS2 refers to the BS2 TAAATTAAAT consensus sequence, SD refers to the Shine-Dalgarno box of the various 
promoter elements, NCR refers to the region between the -24/-12 element and the translational start site, Ec refers to E. coli and luc 
refers to the luciferase gene. The NCR of flaB was chosen because FlaB is ubiquitously expressed in B. burgdorferi and also because 
it is not RpoN-dependent. The foreign sequence we chose was from glnALG in E. coli, which also has an RpoN-dependent promoter 
(Reitzer and Schneider, 2001). The plasmids will be referred to as 5a to 5f respectively throughout the rest of this dissertation. 
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Insert Direction Primer Sequence 
For Figure 5d Forward 5'- AGATCTTGGCACAGTTTTTGCAT -3' 
  Reverse 5'- CATATGTATTATATTTTCTCCCC -3' 
For Figure 5e Forward 5'- AGATCTTGGCACAGATTTCGCTT -3' 
  Reverse 5'- CATATGACTTTAACTCTCCTGGA -3' 
For Figure 5f Forward 5'- AGATCTTGGCACAGTTTTTGCATTATCTTTTTTACGGCGACAC -3' 
  Reverse 5'- CATATGACTTTAACTCTCCTGGA -3' 
 
  
3
5
 
36 
 
Table 2. Primer sequences for cloning of desired DNA fragments, as explained in the “Materials and Methods” section entitled 
“Construction of luciferase reporter plasmids.” 
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RESULTS 
The degradation of BosR 
As suggested by Haijun Xu, a previous postdoctoral scholar in the Yang lab, 
while the mRNA transcript levels of BosR are not significantly different between the two 
culture conditions of room temperature and 37°C, the BosR protein can only be detected 
at 37°C but not room temperature (Figure 6). We hypothesized that a protease may be 
active at 23°C so we conducted a room-temperature protein degradation assay by mixing 
purified rBosR with CFE of B31-MI cultured to stationary phase at room temperature 
(RT-CFE) and 37°C (37-CFE) in a 1:2 ratio of rBosR to CFE. The Coomassie-stained 
SDS-PAGEs in Figure 7a show that rBosR is completely degraded after 48 hours when 
incubated with RT-CFE. Notice that in the 48-hour SDS-PAGE (Figure 7a, right panel), 
the BSA band appears to retain its color intensity.  
Since BosR is not present in such a high amount under physiological conditions, 
we scaled down the ratio of rBosR to CFE from 1:2 to 1:100 to better reflect in vivo 
conditions and also to narrow down the time frame for BosR degradation. The data we 
generated from the immunoblots in this experiment confirmed the data from SDS-
PAGEs. Figure 7b shows the Western blot analysis which suggests that RT-CFE 
degrades rBosR within 12 hours, whereas 37-CFE does not degrade rBosR. The slight 
decrease in rBosR level at 24 and 48 hours in the 37°C group probably reflects the 
instability of the low amount of BosR used in the experiment when left at room 
temperature in an inconducive environment for a prolonged period. Figure 7c sharpens 
the time frame for BosR degradation, showing that rBosR begins to be degraded after 2 
hours and is nearly completely degraded at 12 hours. Taken together, the SDS-PAGEs 
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and immunoblots suggest that BosR is degraded by a protease that is only active when B. 
burgdorferi is cultured at room temperature, and the protease exhibits some specificity 
with regards to its substrate. 
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Figure 6. Expression levels of bosR mRNA (a) and BosR protein (b) in B. burgdorferi 
wild-type strain B31-MI at room temperature (RT) and 37°C. RT cultures mimic tick 
vector physiological conditions whereas 37°C cultures mimic mammalian host 
physiological conditions. The protein ladder used in the immunoblots in (b) was Fisher 
BioReagents EZ-Run Prestained Rec Protein Ladder. 
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Figure 7. Time-course experiments of BosR degradation by B31-MI CFE. (a) Coomassie-
stained SDS-PAGEs. The protein ladder used was Fisher BioReagents® EZ-Run® 
Prestained Rec Protein Ladder. (b) and (c) Immunoblots of rBosR using FlaB as a loading 
control. The appearance of two bands when blotting for rBosR is due to the purification 
of rBosR always yielding two bands despite several different attempts at protein 
isolation. We have not yet been able to identify the cause but speculate that it may be due 
to dimerization of rBosR. The antibody to rBosR is based on the isolated protein. 
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Borrelia transformations with luciferase reporter plasmid constructs 
Although Blevins et al. and Ouyang et al. have both demonstrated that BosR is a 
DNA-binding transcriptional activator of PrpoS in vitro, to date there has not been any 
study confirming those studies in vivo. To address that lack of knowledge, we 
electrotransformed the luciferase reporter plasmid constructs from Figure 5 into B. 
burgdorferi bosR mutant strain OY10/H3 and wild-type strain B31-MI, the parental strain 
of OY10/H3. The bosR mutant strain was generously provided by Zhiming Ouyang. 
Because transformation of B. burgdorferi is notoriously difficult, we unfortunately were 
unable to generate all the transformants that we needed. The successful transformants 
were: constructs from Figure 5a-c and e-f in B31-MI, and constructs from Figure 5a and c 
in OY10/H3.  
 
Contribution of the putative BosR binding site to rpoS expression 
The results shown in Figure 8a suggest that the absence of BS3 does not abolish 
rpoS transcription, as evidenced by high luciferase activity of the 5b wild-type strain 
compared to the negative control, and that BS2 is sufficient for rpoS induction, as 
evidenced by high luciferase activity of the 5c wild-type strain as compared to negative 
control. The much higher luciferase activity of the 5c wild-type strain as compared to the 
5b wild-type strain could be due to regulation of the flaB non-coding region or another 
form of rpoS regulation and these will be addressed in the “Discussion” section. Figure 
8b shows that BosR is most likely required for transcriptional activation of PrpoS since 
the bosR null mutant transformed with the 5c plasmid registered much lower luciferase 
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activity compared to its wild-type counterpart. This confirms the studies of Blevins et al. 
and Ouyang et al. that demonstrated BosR binding to PrpoS in separate in vitro assays. 
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Figure 8 (a) and (b). Luciferase activity of different B. burgdorferi transformants. WT 
refers to the wild-type strain B31-MI and BosR- refers to the bosR deletion strain 
OY10/H3. The plasmid constructs are explained in Figure 5. Two clones of each 
transformant were used and the experiments were repeated twice.  
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DISCUSSION 
 The ability of B. burgdorferi to thrive in two completely different environments 
has fascinated researchers ever since the identification of the spirochete as the etiological 
agent of Lyme disease. Many studies on this perseverant microbe have focused on the 
molecular mechanisms behind this skill. After the elucidation of the unusual Rrp2-RpoN-
RpoS pathway as being the mechanistic cascade required for mammalian infection (Yang 
et al., 2003b; Radolf et al., 2012), researchers were surprised again when it emerged that 
there was another required transcriptional activator separate from Rrp2—a protein known 
by its controversial name of BosR (Boylan et al., 2003; Ouyang et al., 2011). Despite the 
importance of BosR in this pathway, no study has yet been published on the regulation of 
this essential protein. Our studies have now paved the way for the illumination of a novel 
mechanism of BosR regulation in B. burgdorferi. Our data show that an as-yet-
unidentified protease is likely responsible for the regulation of BosR and hence, the 
adaptive abilities of B. burgdorferi under disparate vector-host conditions. The annotated 
B. burgdorferi genome alludes to the existence of 21 proteases, so the next step to take is 
to characterize the protease in question and identify it. Since Fur and PerR (the homologs 
of BosR) have been shown to be autoregulatory in other bacteria (Chan et al., 1995; Lee 
et al., 2003; Lee et al., 2007), this possibility should be explored in addition to protease 
identification.  
 Since the publication of in vitro studies that implicated a DNA-binding regulatory 
role of BosR in rpoS transcriptional activation, there has not been any publication 
confirming the results in B. burgdorferi cultures. We decided to fill that gap in 
knowledge by undertaking the in vivo studies using a luciferase reporter assay adapted to 
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the B. burgdorferi system (Blevins, et al., 2007). The data in Figure 8 confirm the in vitro 
studies and lend weight to a possible compensatory effect of the BosR binding sites for 
each other. Alternatively, none of the binding sites may be required for BosR-dependent 
rpoS transcription, with BosR instead interacting with another member of the Rrp2-
RpoN-RpoS pathway such as the Rrp2 protein or RpoN protein, or even the RNA 
polymerase itself to initiate rpoS transcription. This alternative is possible because of the 
existence of Rrp2 as another transcriptional activator of the pathway.  
As mentioned in the “Results” section, the flaB NCR may be regulated by other 
factors and as such, using a foreign NCR will strengthen this study. As a point of interest, 
there has been rather extensive research in several bacterial systems into the control of 
the rpoS gene as well as its protein product that shows that the gene and protein are 
regulated transcriptionally, post-transcriptionally as well as post-translationally. For 
example, RpoS is controlled at all three stages in E. coli, at the transcriptional level in 
Pseudomonas spp. (Venturi, 2003), at the post-transcriptional level in B. burgdorferi 
(Lybecker and Samuels, 2007) and S. typhimurium (Brown and Elliott, 1996). In the 
future, if and when construction of the full range of Borrelia transformants mentioned in 
this dissertation are completed, it will be possible to definitively prove whether or not 
BosR even requires promoter binding in order to initiate rpoS transcription. Given that B. 
burgdorferi has already surprised researchers several times, it would not be a stretch to 
imagine that this steadfast spirochete has a few more tricks up its metaphorical sleeve. 
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